CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review

CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cryoport Inc (Cryoport) is a provider of temperature-controlled supply chain solutions. The company manages its shipments through Cryoportal, a cloud-based logistics management platform. It also provides various services which include cryogenic logistics solutions, lab moves solutions, cold chain logistics accessories and consulting solutions; and edge logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cell for clients. The company offers its services to the biopharmaceuticals, labs, diagnostics, clinical trials, clinics and research facilities; animal health, and reproductive medicines. Its key brands include Cryoport Systems, IntegriCell, CryoStork, MVE Biological Solutions, CRYOPDP and CRYOGENE. Cryoport is headquartered in the Irvine, California, the US.

CryoPort Inc Key Recent Developments

Mar 12,2024: Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 08,2023: Cryoport Reports Third Quarter 2023 Financial Results
Nov 08,2023: Cryoport Reports Third Quarter 2023 Financial Results
Oct 12,2023: Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
CryoPort Inc - Key Facts
CryoPort Inc - Key Employees
CryoPort Inc - Key Employee Biographies
CryoPort Inc - Major Products and Services
CryoPort Inc - History
CryoPort Inc - Company Statement
CryoPort Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
CryoPort Inc - Business Description
Other Break-up: Animal Health
Overview
Performance
Other Break-up: Biopharma/Pharma
Overview
Performance
Other Break-up: Reproductive Medicine
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, the Middle East and Africa
Performance
R&D Overview
CryoPort Inc - SWOT Analysis
SWOT Analysis - Overview
CryoPort Inc - Strengths
CryoPort Inc - Weaknesses
CryoPort Inc - Opportunities
CryoPort Inc - Threats
CryoPort Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
CryoPort Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 12, 2024: Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 08, 2023: Cryoport Reports Third Quarter 2023 Financial Results
Nov 08, 2023: Cryoport Reports Third Quarter 2023 Financial Results
Oct 12, 2023: Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF
Oct 09, 2023: Be The Match BioTherapies and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Sep 14, 2023: Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award
Aug 09, 2023: Cryoport Reports Second Quarter 2023 Financial Results
Jul 12, 2023: Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
May 04, 2023: Cryoport Reports First Quarter 2023 Results
Mar 28, 2023: Cryoport announces multi-Year agreement with inception fertility
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
CryoPort Inc, Key Facts
CryoPort Inc, Key Employees
CryoPort Inc, Key Employee Biographies
CryoPort Inc, Major Products and Services
CryoPort Inc, History
CryoPort Inc, Other Locations
CryoPort Inc, Subsidiaries
CryoPort Inc, Key Competitors
CryoPort Inc, Ratios based on current share price
CryoPort Inc, Annual Ratios
CryoPort Inc, Annual Ratios (Cont...1)
CryoPort Inc, Annual Ratios (Cont...2)
CryoPort Inc, Interim Ratios
CryoPort Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
CryoPort Inc, Performance Chart (2019 - 2023)
CryoPort Inc, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings